Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. Our high purity tirzepatide UK price offers excellent value for research institutions.
With purity exceeding 99%, our tirzepatide demonstrates superior efficacy in glucose control and weight management studies compared to similar compounds. The dual agonist behavior produces greater reductions of hyperglycemia in research models.
Our competitive tirzepatide UK price makes this innovative peptide accessible for research purposes. The lyophilized powder form ensures stability and easy reconstitution for laboratory use.
For researchers studying metabolic disorders, our tirzepatide offers a valuable tool with demonstrated effects on beta-cell function preservation and cardiovascular improvement in preclinical models.